购物车
- 全部删除
- 您的购物车当前为空
p38 MAPK-IN-1 displays sustained levels, low clearance, and good bioavailability. p38 MAPK-IN-1 is a novel effective and selective inhibitor of p38 MAPK (IC50: 68 nM).
为众多的药物研发团队赋能,
让新药发现更简单!
p38 MAPK-IN-1 displays sustained levels, low clearance, and good bioavailability. p38 MAPK-IN-1 is a novel effective and selective inhibitor of p38 MAPK (IC50: 68 nM).
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 1,890 | 5日内发货 | |
5 mg | ¥ 2,890 | 5日内发货 | |
25 mg | ¥ 9,620 | 8-10周 | |
50 mg | ¥ 12,500 | 8-10周 | |
100 mg | ¥ 17,500 | 8-10周 | |
1 mL x 10 mM (in DMSO) | ¥ 3,180 | 5日内发货 |
产品描述 | p38 MAPK-IN-1 displays sustained levels, low clearance, and good bioavailability. p38 MAPK-IN-1 is a novel effective and selective inhibitor of p38 MAPK (IC50: 68 nM). |
靶点活性 | p38 MAPK:68 nM |
体内活性 | p38 MAPK-IN-1 dose-dependently inhibits TNFα production (ED50: 0.5 mg/kg). p38 MAPK-IN-1 (1 mg/kg for iv and 10 mg/kg for p.o.) has a t1/2 of 7.4 hours and CL of 2.7 mL/min/kg for iv, and a Cmax of 5.3 μM for p.o. in male wistar rats[1]. |
分子量 | 348.35 |
分子式 | C21H14F2N2O |
CAS No. | 1006378-90-0 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
溶解度信息 | DMSO: 8.33 mg/mL (23.84 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.